The report provides a detailed analysis essential for establishing a bacampicillin production plant. It encompasses all critical aspects necessary for bacampicillin production, including the cost of bacampicillin production, bacampicillin plant cost, bacampicillin production costs, and the overall bacampicillin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a bacampicillin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Bacampicillin is a semi-synthetic antibiotic that belongs to the penicillin group and is mainly used for the treatment of bacterial infections. It is primarily prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain gastrointestinal infections caused by susceptible bacteria. It is an oral prodrug of ampicillin, which means it converts into ampicillin in the body after absorption to fight bacterial infections. It is also used in the formulation of tablets and capsules intended for outpatient therapy. Moreover, it is widely used in hospitals and clinics as an oral antibiotic due to its good absorption and effectiveness. Additionally, it is also used in medical research and drug formulation processes for improving antibiotic delivery and patient compliance.
The market for bacampicillin is driven by its application as an oral antibiotic in paediatric and general medicine for managing common bacterial illnesses, which supports its demand in the pharmaceutical industry. Its usage as a drug in the treatment of respiratory tract infections, urinary tract infections, skin infections, and ear infections significantly promotes its demand in the medical and pharmaceutical industries. Its application in managing acute exacerbations of chronic bronchitis and other community-acquired infections further boosts its demand in the public healthcare sector. Its demand as a reliable option for treating common bacterial infections also drives its market expansion. The rising incidence of common bacterial infections and the continued need for effective penicillin-based therapies further contribute to its demand across hospitals and clinics. Additionally, industrial bacampicillin procurement is influenced by factors such as the cost and availability of raw materials, regulatory approvals, quality compliance standards, and environmental requirements. Improvements in production processes, dependable supplier networks, sustainable production practices, and efficient supply chain management also play a significant role in shaping its sourcing decisions.
Raw Material for Bacampicillin Production
According to the bacampicillin production plant project report, the major raw materials for bacampicillin production include sodium 6-(D-α-azidophenylacetamido)penicillinate and α-chlorodiethylcarbonate.
Production Process of Bacampicillin
The extensive bacampicillin production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of bacampicillin begins with the reaction of sodium 6-(D-α-azidophenylacetamido)penicillinate with α-chlorodiethylcarbonate in the presence of sodium bicarbonate, which leads to the formation of an ethoxycarbonyloxyethyl ester intermediate. This step introduces the protective ester group while maintaining the β-lactam structure of the penicillin core. Then, the resulting compound is dissolved in an organic solvent and subjected to catalytic hydrogenation over palladium on carbon, which converts the azido group into an amino group. After completion of the reduction, the catalyst is removed by filtration, and the solution is treated with dilute acid to transfer the product into the aqueous phase as its hydrochloride salt. The aqueous layer is then isolated and lyophilised to obtain the purified product, which is further converted into its sodium salt form to give bacampicillin sodium.
Bacampicillin is a semi-synthetic beta-lactam antibiotic of the aminopenicillin class, and it functions as a prodrug of ampicillin with significantly improved oral bioavailability. It appears as a white or almost white hygroscopic powder or granules. The molecular formula of the compound is C21H27N3O7S, and its molar mass is 465.52 g/mol. Bacampicillin is a weak base, and this property contributes to its excellent absorption in the duodenum, achieving 80–98% bioavailability compared to only 30–55% for ampicillin. It has a boiling point of 678.4 degree Celsius, and its density is around 1.37 gm/cm3. The compound was marketed under the brand names Spectrobid by Pfizer and Penglobe by AstraZeneca. In double-blind comparison studies, bacampicillin was shown to be as effective as ampicillin when administered at half the dose. The compound is contraindicated in individuals with known hypersensitivity to penicillins, cephalosporins, or carbapenems. Common adverse effects associated with its use include gastrointestinal disturbances, skin rash, and hypersensitivity reactions. It is recommended to store the compound in a dry environment, protected from moisture due to its hygroscopic nature.